In Vivo Microbeam Radiation Therapy at a Conventional Small Animal Irradiator
Author:
Ahmed Mabroor123ORCID, Bicher Sandra12, Combs Stephanie Elisabeth12, Lindner Rainer2, Raulefs Susanne12, Schmid Thomas E.12, Spasova Suzana123, Stolz Jessica12, Wilkens Jan Jakob13ORCID, Winter Johanna1234ORCID, Bartzsch Stefan124ORCID
Affiliation:
1. Department of Radiation Oncology, School of Medicine and Klinikum rechts der Isar, Technical University of Munich, 81675 Munich, Germany 2. Helmholtz Zentrum München GmbH, German Research Center for Environmental Health, Institute of Radiation Medicine, 85764 Neuherberg, Germany 3. Department of Physics, School of Natural Sciences, Technical University of Munich, 85748 Garching, Germany 4. Heinz Maier-Leibnitz Zentrum (MLZ), 85748 Garching, Germany
Abstract
Microbeam radiation therapy (MRT) is a still pre-clinical form of spatially fractionated radiotherapy, which uses an array of micrometer-wide, planar beams of X-ray radiation. The dose modulation in MRT has proven effective in the treatment of tumors while being well tolerated by normal tissue. Research on understanding the underlying biological mechanisms mostly requires large third-generation synchrotrons. In this study, we aimed to develop a preclinical treatment environment that would allow MRT independent of synchrotrons. We built a compact microbeam setup for pre-clinical experiments within a small animal irradiator and present in vivo MRT application, including treatment planning, dosimetry, and animal positioning. The brain of an immobilized mouse was treated with MRT, excised, and immunohistochemically stained against γH2AX for DNA double-strand breaks. We developed a comprehensive treatment planning system by adjusting an existing dose calculation algorithm to our setup and attaching it to the open-source software 3D-Slicer. Predicted doses in treatment planning agreed within 10% with film dosimetry readings. We demonstrated the feasibility of MRT exposures in vivo at a compact source and showed that the microbeam pattern is observable in histological sections of a mouse brain. The platform developed in this study will be used for pre-clinical research of MRT.
Reference32 articles.
1. World Health Organization (2023, December 11). New WHO/IAEA Publication Provides Guidance on Radiotherapy Equipment to Fight Cancer. Available online: https://www.who.int/news/item/05-03-2021-new-who-iaea-publication-provides-guidance-on-radiotherapy-equipment-to-fight-cancer. 2. Baskar, R., Dai, J., Wenlong, N., Yeo, R., and Yeoh, K.W. (2014). Biological response of cancer cells to radiation treatment. Front. Mol. Biosci., 1. 3. Laissue, J.A., Lyubimova, N., Wagner, H.P., Archer, D.W., Slatkin, D.N., Di Michiel, M., Nemoz, C., Renier, M., Brauer, E., and Spanne, P.O. (1999, January 22–23). Microbeam radiation therapy. Proceedings of the Medical Applications of Penetrating Radiation, SPIE, Denver, CO, USA. 4. Laissue, J.A., Blattmann, H., Di Michiel, M., Slatkin, D.N., Lyubimova, N., Guzman, R., Zimmermann, W., Birrer, S., Bley, T., and Kircher, P. (2001, January 1–2). Weanling piglet cerebellum: A surrogate for tolerance to MRT (microbeam radiation therapy) in pediatric neuro-oncology. Proceedings of the Penetrating Radiation Systems and Applications III, SPIE, San Diego, CA, USA. 5. In vivo two-photon microscopy study of short-term effects of microbeam irradiation on normal mouse brain microvasculature;Serduc;Int. J. Radiat. Oncol. Biol. Phys.,2006
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|